Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.
暂无分享,去创建一个
[1] L. Nardo,et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. , 2009, Fertility and sterility.
[2] D. Barad,et al. Supplementation with dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-müllerian hormone levels , 2009 .
[3] D. Barad,et al. Age specific anti-müllerian hormone (AMH) levels discriminate at each age between poorer and better oocyte yields , 2009 .
[4] D. Barad,et al. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. , 2009, Fertility and sterility.
[5] D. Barad,et al. Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. , 2009, Fertility and sterility.
[6] M. Eijkemans,et al. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. , 2009, The Journal of clinical endocrinology and metabolism.
[7] B. Mol,et al. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. , 2009, Fertility and sterility.
[8] V. Kushnir,et al. Aneuploidy in abortuses following IVF and ICSI , 2009, Journal of Assisted Reproduction and Genetics.
[9] J. Segars,et al. A new approach to ovarian reserve testing. , 2008, Fertility and sterility.
[10] E Godehardt,et al. Relevance of anti-Mullerian hormone measurement in a routine IVF program. , 2008, Human reproduction.
[11] P. Bischof,et al. Undetectable serum anti-Müllerian hormone levels and occurrence of ongoing pregnancy. , 2008, Fertility and sterility.
[12] D. Barad,et al. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function , 2007, Journal of Assisted Reproduction and Genetics.
[13] D. Barad,et al. Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. , 2007, Fertility and sterility.
[14] D. Barad,et al. Age-Specific Levels for Basal Follicle-Stimulating Hormone Assessment of Ovarian Function , 2007, Obstetrics and gynecology.
[15] B. Mol,et al. A systematic review of tests predicting ovarian reserve and IVF outcome. , 2006, Human reproduction update.
[16] O. Shebl,et al. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. , 2006, Human reproduction.
[17] J. Visser,et al. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. , 2006, Endocrinology.
[18] R. Fleming,et al. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone. , 2006, Human reproduction.
[19] Alan R Gilmore,et al. Anti‐müllerian hormone as a marker of ovarian reserve * , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.
[20] D. Seifer,et al. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. , 2004, Fertility and sterility.
[21] Toner Jp. Ovarian reserve, female age and the chance for successful pregnancy. , 2003 .
[22] L. Schieve,et al. Spontaneous Abortion Among Pregnancies Conceived Using Assisted Reproductive Technology in the United States , 2003, Obstetrics and gynecology.
[23] J. Liss,et al. Prognosis following in vitro fertilization-embryo transfer (IVF-ET) in patients with elevated day 2 or 3 serum follicle stimulating hormone (FSH) is better in younger vs older patients. , 2000, Clinical and experimental obstetrics & gynecology.
[24] A. Levi,et al. Reproductive outcome in patients with diminished ovarian reserve. , 2001, Fertility and sterility.
[25] N. Gleicher,et al. A rational approach to the management of low responders in in-vitro fertilization. , 1999, Human reproduction.